Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Long-Term Deferred Tax: 2018-2020

Historic Long-Term Deferred Tax for Genmab A (GMAB) over the last 3 years, with Dec 2020 value amounting to $20.6 million.

  • Genmab A's Long-Term Deferred Tax fell 14.83% to $21.02 in Q2 2021 from the same period last year, while for Jun 2021 it was $21.02, marking a year-over-year decrease of 14.83%. This contributed to the annual value of $20.6 million for FY2020, which is 204.19% up from last year.
  • Latest data reveals that Genmab A reported Long-Term Deferred Tax of $20.6 million as of FY2020, which was up 204.19% from $6.8 million recorded in FY2019.
  • Over the past 5 years, Genmab A's Long-Term Deferred Tax peaked at $42.7 million during FY2018, and registered a low of $6.8 million during FY2019.
  • Its 3-year average for Long-Term Deferred Tax is $23.3 million, with a median of $20.6 million in 2020.
  • Its Long-Term Deferred Tax has fluctuated over the past 5 years, first crashed by 84.18% in 2019, then soared by 204.19% in 2020.
  • Over the past 3 years, Genmab A's Long-Term Deferred Tax (Yearly) stood at $42.7 million in 2018, then slumped by 84.18% to $6.8 million in 2019, then soared by 204.19% to $20.6 million in 2020.